WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS), a biopharmaceutical company focused on discovering, developing, and commercializing a cure for patients suffering from chronic Hepatitis B virus infection, has announced its participation in two imminent investor conferences in Miami, Florida.
The management team of Arbutus will first present at the Barclays 26th Annual Global Healthcare Conference on March 12, 2024, at 2:05 pm ET. The conference, known for its global appeal, brings together healthcare professionals, industry leaders, and investors to discuss the latest trends, advancements, and challenges in the healthcare sector.
Following this, the team will also attend the Jefferies Biotech on the Bay Summit on March 13, 2024. This event is a notable gathering in the biotech sector, offering an opportunity for companies to engage with investors and share insights into their operations and strategic plans.
For those unable to attend the Barclays conference, Arbutus has made provisions for a live webcast of the formal presentation. Interested parties can access this on the Arbutus website. An archived replay of the webcast will also be available for a limited period following the event, ensuring that those who cannot tune in live do not miss out on the insights shared by the Arbutus management team.
These upcoming presentations provide an opportunity for Arbutus to share its latest advancements and strategic outlook with a broad audience, potentially attracting further investment and interest in its ongoing mission to discover and develop a cure for chronic Hepatitis B virus infection.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.